Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca2+-binding protein

被引:69
作者
Gartner, W
Lang, W
Leutmetzer, F
Domanovits, H
Waldhäusl, W
Wagner, L
机构
[1] Univ Vienna, Dept Med 3, Div Clin Endocrinol & Metab, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Emergency Med, A-1090 Vienna, Austria
关键词
D O I
10.1093/cercor/11.12.1161
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recently we identified a novel EF-hand Ca-binding protein termed secretagogin, which is expressed in neuroendocrine cells. Immunohistochemical investigations, using a murine monoclonal and an affinity purified rabbit polyclonal anti-secretagogin antibody as well as Northern-blat and Western-blot analysis revealed a neuron-specific cerebral expression pattern. Secretagogin was detected in high quantity in basket and stellate cells of the cerebellar cortex, in secretary neurons of the anterior part of the pituitary gland and in singular neurons of the frontal and parietal neocortex. Remarkable staining intensity was observed in hypothalamic and in hippocampal neurons. Using a newly developed sandwich capture ELISA we show presence of secretagogin in serum of patients suffering from hypoxic neuronal damage. In sera obtained from 32 patients with different forms of neurological symptoms due to focal cerebral ischemia, secretagogin levels ranged from 3 to 236 pg/ml, with highest levels observed on days 2 and 3 after infarction. Three patients exhibiting minor, reversible neurological deficits had nondetectable serum secretagogin levels at time points of testing. In 50 control sera, secretagogin was below the detection limit of our ELISA. Parallel analysis of secretagogin and the established neurobiochemical marker S-100B in 14 representative patients revealed comparable results. However, S-100B levels were higher and exhibited different kinetics than secretagogin. Our data present the cerebral expression pattern of secretagogin and give evidence that this protein might represent a clinically relevant serum marker indicative for neuronal damage.
引用
收藏
页码:1161 / 1169
页数:9
相关论文
共 51 条
[1]   Serum S-100 protein, relationship to clinical outcome in acute stroke [J].
Abraha, HD ;
Butterworth, RJ ;
Bath, PMW ;
Wassif, WS ;
Garthwaite, J ;
Sherwood, RA .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :546-550
[2]   Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene [J].
Airaksinen, MS ;
Eilers, J ;
Garaschuk, O ;
Thoenen, H ;
Konnerth, A ;
Meyer, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1488-1493
[3]   High level calcineurin activity predisposes neuronal cells to apoptosis [J].
Asai, A ;
Qiu, JH ;
Narita, Y ;
Chi, S ;
Saito, N ;
Shinoura, N ;
Hamada, H ;
Kuchino, Y ;
Kirino, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34450-34458
[4]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[5]   S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction [J].
Buttner, T ;
Weyers, S ;
Postert, T ;
Sprengelmeyer, R ;
Kuhn, W .
STROKE, 1997, 28 (10) :1961-1965
[6]   Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment [J].
Buxbaum, JD ;
Choi, EK ;
Luo, YX ;
Lilliehook, C ;
Crowley, AC ;
Merriam, DE ;
Wasco, W .
NATURE MEDICINE, 1998, 4 (10) :1177-1181
[7]   DREAM is a Ca2+-regulated transcriptional repressor [J].
Carrión, AM ;
Link, WA ;
Ledo, F ;
Mellström, B ;
Naranjo, JR .
NATURE, 1999, 398 (6722) :80-84
[8]   CALBINDIN-D-28K AND PARVALBUMIN IN THE RAT NERVOUS-SYSTEM [J].
CELIO, MR .
NEUROSCIENCE, 1990, 35 (02) :375-475
[9]  
Celio RC, 1996, GUIDEBOOK CALCIUM BI
[10]   CALCIUM BUFFERING PROPERTIES OF CALBINDIN-D(28K) AND PARVALBUMIN IN RAT SENSORY NEURONS [J].
CHARD, PS ;
BLEAKMAN, D ;
CHRISTAKOS, S ;
FULLMER, CS ;
MILLER, RJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 472 :341-357